A model for undertaking effectiveness and cost-effectiveness analyses of primary preventive strategies in cardiovascular disease

European Journal of Preventive Cardiology

Volumn 13, Issue 4, 2006, Pages 515-522

  Liew, Danny ^a   Lim, Stephen S ^b   Bertram, Melanie ^b   Mcneil, John J ^a   Vos, Theo ^b  

^a MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

antihypertensive treatment; aspirin; cardiovascular disease; cost effectiveness; statins

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DISABILITY; DRUG EFFICACY; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH SERVICE; HUMAN; HYPOTHESIS; INTERVENTION STUDY; LIFE; MALE; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; MONTE CARLO METHOD; PATIENT COMPLIANCE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PUBLIC HEALTH; RISK REDUCTION; SENSITIVITY ANALYSIS; TREATMENT WITHDRAWAL; UNCERTAINTY;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMIC; PRIMARY PREVENTION; RETROSPECTIVE STUDIES; VICTORIA;

EID: 33746727743     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000224488.03221.97     Document Type: Article

References (30)

1. Liew D, McNeil JJ, Peeters A, Lim SS, Vos T. Epidemiological modelling (including economic modelling) and its role in preventive drug therapy. Med J Aust 2002; 177: 364–367.
2. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases. Part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104: 2746–2753.
3. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases. Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001; 104: 2855–2864.
4. McNeil JJ, Peeters A, Liew D, Lim S, Vos T. A model for predicting the future incidence of coronary heart disease within percentiles of coronary heart disease risk. J Cardiovasc Risk 2001; 8: 31–37.
5. Lilford RJ, Pauker SG, Braunholtz DA, Chard J. Decision analysis and the implementation of research findings. BMJ 1998; 317: 405–409.
6. Wesley D. Life table analysis. J Insur Med 1998; 30: 247–254.
7. Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 1998; 13: 397–409.
8. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996; 276: 1253–1258.
9. Briggs AH. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics 2000; 17: 479–500.
10. Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1990; 121: 293–298.
11. Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile. AHA Medical/Scientific Statement. Circulation 1991; 83: 356–362.
12. Odell PM, Anderson KM, Kannel WB. New models for predicting cardiovascular events. J Clin Epidemiol 1994; 47: 583–592.
13. D'Agostino RB, Russell MW, Huse DM, Ellison RC, Silbershatz H, Wilson PW, Hartz SC. Primary and subsequent coronary risk appraisal: new results from The Framingham Study. Am Heart J 2000; 139: 272–281.
14. Victorian Department of Human Services Health Data Standards and Systems Unit. VAED Manual, 13th ed. Melbourne: Victorian DHS; 2003. Available at: http://hdss.health.vic.gov.au. Accessed: 12 January 2006.
15. Australian Bureau of Statistics. 2001 Census of Population and Housing. Canberra: ABS; 2001. Available at: http://www.abs.gov.au. Accessed: 12 January 2006.
16. Thrift AG, Dewey HM, Macdonell RA, McNeil JJ, Donnan GA. Stroke incidence on the east coast of Australia: the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 2000; 31: 2087–2092.
17. McElduff P, Dobson A, Jamrozik K, Hobbs M. The WHO MONICA Study, Australia, 1984–93: a summary of the Newcastle and Perth MONICA Projects. Canberra: Australian Institute of Health and Welfare; 2000.
18. Victorian Department of Human Services, Public Health and Development Division. The Victorian Burden of Disease Study: Mortality. Melbourne: Victorian DHS; 1999. Available at: http://www.dhs.vic.gov.au/phd/9903009/index.htm. Accessed: 12 January 2006.
19. Mathers C, Vos T, Stevenson C. The burden of disease and injury in Australia. Canberra: Australian Institute of Health and Welfare; 1999.
20. KPMG Health, Education and Community Services Group 2000–01 Cost Weight Study. A report to the Victorian Department of Human Services. Melbourne: Victorian DHS; 2001.
21. Dewey HM, Thrift AG, Mihalopoulos C, Carter R, Macdonell RA, McNeil JJ, Donnan GA. Cost of stroke in Australia from a societal perspective: results from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 2001; 32: 2409–2416.
22. Nelson MR, Liew D, Bertram M, Vos T. Epidemiological modelling of routine use of low dose aspirin for the primary prevention of coronary heart disease and stroke in those aged ≤ 70. BMJ 2005; 330: 1306. E-pub 20 May 2005.
23. Weinstein MC, Coxson PG, Williams LW, Pass TM, Stason WB, Goldman L. Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. Am J Public Health 1987; 77: 1417–1426.
24. Johannesson M, Hedbrant J, Jonsson B. A computer simulation model for cost-effectiveness analysis of cardiovascular disease prevention. Med Inform 1991; 16: 355–362.
25. Matchar DB, Samsa GP, Matthews J.R., Ancukiewicz M, Parmigiani G, Hasselblad V. The Stroke Prevention Policy Model: linking evidence and clinical decisions. Ann Intern Med 1997; 127: 704–711.
26. Cucherat M, Boissel JP. A mathematical model for the determination of the optimum value of the treatment threshold for a continuous risk factor. Eur J Epidemiol 1998; 14: 23–29.
27. Lindholm L, Hallgren CG, Boman K, Markgren K, Weinehall L, Ogren JE. Cost-effectiveness analysis with defined budget: how to distribute resources for the prevention of cardiovascular disease? Health Policy 1999; 48: 155–170.
28. Mui SL. Projecting coronary heart disease incidence and cost in Australia: results from the incidence module of the Cardiovascular Disease Policy Model. Aust N Z J Public Health 1999; 23: 11–19.
29. Babad H, Sanderson C, Naidoo B, White I, Wang D. The development of a simulation model of primary prevention strategies for coronary heart disease. Health Care Manag Sci 2002; 5: 269–274.
30. Cooper K, Davies R, Roderick P, Chase D, Raftery J. The development of a simulation model of the treatment of coronary heart disease. Health Care Manag Sci 2002; 5: 259–267.